|Articles|December 4, 2020
HIC Analysis of Drug-to-Antibody Ratio
Author(s)Agilent Technologies, Inc.
This application note demonstrates the DAR determination of brentuximab vedotin using HIC. Excellent reproducibility was found with the Agilent 1290 Infinity II Bio LC.
Related Content
Trending on LCGC International
1
ASMS 2026 Award Winners Highlight the Future of Mass Spectrometry
2
How AI and Machine Learning Are Reshaping Separations Science at HPLC 2026
3
ASMS 2026: Phantom Metabolites and the Hidden Chemistry of Electrospray Ionization
4
Hyphenated Chromatography Methods: Successes and Remaining Challenges
5